Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
altered states of consciousness
Alzheimer's disease
Alzheimer's disease, treatment of
amphetamines
amyotrophic lateral sclerosis
analgesic
anesthesia, general
anesthesia, local
anesthesia, spinal
anisocoria
antibiotics
antibiotics, neurologic complications with
anticholinesterase
anticoagulant, treatment
anticonvulsants
anticonvulsants, untoward effects of
antidepressant
anxiety
arthralgia
asterixis
autonomic dysfunction
baclofen
basal ganglia
basal ganglia, lesion of
basal ganglia, lesion, bilateral
benzodiazepine
beta adrenergic blocker
blindness
calcium antagonist
camphor
capsaicin
carbon monoxide poisoning
carbon monoxide poisoning, chronic
carboxyhemoglobin
CAT scan, abnormal
central venous catheter
cerebellar lesion
cerebellum
cerebral cortex
cerebral embolism
cerebral ischemia
cerebrovascular accident
cerebrovascular accident, acute management of
cervical spine injury
Cheyne Stokes respirations
chlorambucil
cluster headache
cocaine
cognition
coma
competency
complications
confusion
conjunctival injection
contrast agents, neurotoxicity of
controversies in neurology
corpus callosum, lesion of
cost effectiveness
cyclosporine
decompression sickness
deep gray nuclei
dementia
DHE
diagnostic criteria
differential diagnosis
dilantin
diving
dizziness
drowsiness
drug induced neurologic disorders
dying
dyspnea
edema, periorbital
efficacy
electrocoagulation
embolism
embolism, air
emergencies, neurologic
encephalopathy
encephalopathy, post anoxic
ephedrine
epilepsia partialis continua
ergonovine
ergotamine
ergotism
ethics in neurology
euthanasia
evidence-based research
fatigue
folic acid
gangrene
globus pallidus
globus pallidus, lesion of
globus pallidus, lesion of, bilateral
headache
headache, classification
headache, intractable
headache, prophylaxis
headache, recurrent
headache, severe
headache, treatment of
headache, unilateral
hearing loss
hippocampus
Horner's syndrome
hunger
hydergine
hyperalimentation
hyperbaric oxygen
hyperbaric treatment
hypercapnia
hypothalamus
hypothalamus, disturbance of
hypoxia
iatrogenic neurologic disorders
immunosuppression
industrial neurologic disorders
intravenous
intravenous line
leg weakness, bilateral
lenticular nucleus, lesion of, bilateral
level of consciousness, decreased
lidocaine
life support, withdrawal of
life support, withholding of
life sustaining treatment
lithium
locked-in syndrome
low back pain
medical-legal aspects of neurology
memory, disorder, treatment of
mental status, abnormal
methysergide
migraine
migraine, intractable
miosis
morphine
mortality
motor neuron disease
MRI
MRI, abnormal
MRI, diffusion weighted
MRI, false negative
MRI, spinal cord
multiple sclerosis
multiple sclerosis, treatment of
muscle pain
muscular dystrophy
myoclonus
nalidixic acid
narcotic analgesics
nasal spray
nausea and vomiting
nerve block
neuroleptic
neurologic complications
neurologic complications of, chronic pulmonary disease
neurologic disease, diagnoses of
neurologic signs
neurologic symptoms
neurotoxic
neurotoxin
nonsteroidal anti-inflammatory drug
nootropics
nursing home
obesity
occupational neurologic disorders
oxygen therapy
pain
pain, abdominal
pain, severe
palliative care
papaverine
papilledema
paresthesias
Parkinsonism syndrome
patient information and support
penicillin
personality change
phencyclidine poisoning
phenobarbital
phenylpropanolamine
phlebotomy
physician assisted suicide
physostigmine
piracetam
poison, neurologic problems with
precipitating factors
pregnancy, neurologic complications in
prevention of neurologic disorders
prognosis
propranolol
psychological testing
ptosis
ptosis, unilateral
pulmonary edema
quality of life
radiation necrosis
radiation therapy, CNS treatment and complications with
respirations in CNS disease
respirator
respiratory failure
review article
rhinorrhea
right to die
scuba diving
sedation
seizure
seizure, drug-induced
seizure, focal
skin, cherry-red
sodium nitroprusside
sodium valproate
sodium valproate, intravenous
spinal cord
spinal cord, cervical
spinal cord, injury of
spinal cord, lesion of
sports medicine, neurology of
status epilepticus
stimulation, deep brain
stimulation, thalamic
stuporous
suicide
sumatriptan
sympathomimetic drugs
tension headache
thalamus, lesion of
treatment of neurologic disorder
tremor
triptans
valium
vasodilating agents
vasodilating agents in treatment of cerebrovascular disease
vasospasm, cerebral
verapamil
vest restraints
vitamin K
weakness
white matter disease
zolmitriptan
Showing articles 2700 to 2750 of 10650 << Previous Next >>

Clinicopath Conf. Rickets Due to Vitamin D Deficiency
NEJM 360:398-407, Case 3-2009, 2009

Association Between Recent Sports Activity, Sports Activity in Young Adulthood, and Stroke
Stroke 40:425-431, Grau,A.J.,et al, 2009

Isolated Lateral Sinus Thrombosis: A Series of 62 Patients
Stroke 40:476-481, Damak,M.,et al, 2009

Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009

Assessment of Potential Drug Interactions in Patients with Epilepsy: Impact of Age and Sex
Neurol 72:419-425, Gidal,B.E.,et al, 2009

Neurologic Immune Reconstitution Inflammatory Syndrome in HIV/AIDS: Outcome and Epidemiology
Neurol 72:835-841, McCombe,J.A.,et al, 2009

Cerebral Microbleed Preceding Symptomatic Intracerebral Hemorrhage in a Stroke-Free Person
Neurol 72:763-765, Vernooij,M.W.,et al, 2009

Thrombolytic Therapy for Patients Who Wake-Up With Stroke
Stroke 40:827-832, Barreto,A.D.,et al, 2009

Thrombolysis in Childhood Stroke: Report of 2 Cases and Review of the Literature
Stroke 40:801-807, Arnold,M.,et al, 2009

Can a Subset of Intracerebral Hemorrhage Patients Benefit from Hemostatic Therapy with Recombinant Activated Factor VII?
Stroke 40:833-840, Mayer,S.A.,et al, 2009

Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals from a Special Writing Group of the Stroke Council, American Heart Association
Stroke 40:994-1025, Bederson,J.B.,et al, 2009

A Multicenter, Prospective Pilot Study of Gamma Knife Radiosurgery for Mesial Temporal Lobe Epilepsy: Seizure Response, Adverse Events, and Verbal Memory
Ann Neurol 65:167-175, Barbaro,N.M.,et al, 2009

Disappearing Hyperdense Middle Cerebral Artery Sign in Ischaemic Stroke Patients Treated with Intravenous Thrombolysis: Clinical Course and Prognostic Significance
JNNP 80:273-278,248, Kharitonova,T.,et al, 2009

Neurosarcoidosis: A Study of 30 New Cases
JNNP 80:297-304, Joseph,F.G. &Scolding,N.J., 2009

Oral Fingolimod (FTY720) in Multiple Sclerosis: Two-Year Results of a Phase II Extension Study
Neurol 72:73-79, OConnor,P.,et al, 2009

Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients with Advanced Parkinson Disease: A Randomized Controlled Trial
JAMA 301:63-73,104, Weaver,F.M.,et al, 2009

Community-Acquired Bacterial Meningitis in Elderly Patients: Experience Over 30 Years
Medicine 88:115-119, Cabellos,C.,et al, 2009

Intravascular Lymphoma Masquerading as Multiembolic Stroke Developing After Coronary Artery By-Pass Surgery
The Neurologist 15:98-101, Sumer,M.,et al, 2009

Alzheimers Disease
BMJ 338:467-471, Burns,A. &Iliffe,S., 2009

Prescribe Prednisolone Alone for Bells Palsy Diagnosed Within 72 Hours of Symptom Onset
BMJ 338:410-411, Madhok,V.,et al, 2009

Sustained-Release Oral Fampridine in Multiple Sclerosis: A Randomised, Double-Blind, Controlled Trial
Lancet 373:732-738, Goodman,A.D.,et al, 2009

Diagnosis and New Treatment in Muscle Channelopathies
JNNP 80:360-365, Meola,G.,et al, 2009

Recurrent Pericarditis Due to Natalizumab Treatment
Neurol 72:1616-1617, Cohen,M.,et al, 2009

Incidence and Mortality Rates of Myasthenia Gravis and Myasthenic Crisis in US Hospitals
Neurol 72:1548-1554, Alshekhlee,A.,et al, 2009

Donepezil Treatment of Patients with MCI: A 48-Week Randomized, Placebo-Controlled Trial
Neurol 72:1555-1561, Doody,R.S.,et al, 2009

Telemedicine Versus Telephone for Remote Emergency Stroke Consultations: A Critically Appraised Topic
The Neurologist 15:163-166, Capampngan,D.J.,et al, 2009

Memantine Induces Reversible Neurologic Impairment in Patients with MS
Neurol 72:1630-1633, Villoslada,P.,et al, 2009

Antivenom for Critically Ill Children with Neurotoxicity from Scorpion Stings
NEJM 360:2090-2098, Boyer,L.V.,et al, 2009

Long-Term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
Arch Neurol 66:563-570, Parkinson Sutdy Group CALM Cohort Investigators, 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Cost-Effectiveness of Preventive Treatment of Intracranial Aneurysms: New Data and Uncertainties
Neurol 73:258-265,254, Greving,J.P.,et al, 2009

Hearing Improvement After Bevacizumab in Patients with Neurofibromatosis Type 2
NEJM 361:358-367, Plotkin,S.R.,et al, 2009

Recurrent Cerebral Ischemia in Medically Treated Patent Foramen Ovale: A Meta-Analysis
Neurol 73:89-97,84, Almekhlafi,M.A.,et al, 2009

Facial Pain
The Neurologist 15:171-177, Graff-Radford,S.B., 2009

Tubular Diskectomy vs Conventional Microdiskectomy for Sciatica: A Randomized Controlled Trial
JAMA 302:149-158,216, Arts,M.P.,et al, 2009

Association Between Clinical Conversion to Multiple Sclerosis in Radiologically Isolated Syndrome and Magnetic Resonance Imaging, Cerebrospinal Fluid, and Visual Evoked Potential: Follow-Up of 70 Patients
Arch Neurol 66:841-846, Lebrun,C.,et al, 2009

Frequency, Characteristics, and Risk Factors for Amiodarone Neurotoxicity
Arch Neurol 66:865-869, Orr,C.F. &Ahlskog,E., 2009

Neurological Consequences of Atrioesophageal Fistula After Radiofrequency Ablation in Atrial Fibrillation
Arch Neurol 66:884-887, St�llberger,C.,et al, 2009

Long-Term Effects of Pallidal Deep Brain Stimulation in Tradive Dystonia
Neurol 73:53-58, Gruber,D.,et al, 2009

Intraarterial Thrombolysis Within the First Three Hours After Acute Ischemic Stroke in Selected Patients
Stroke 40:2611-2612,2615, Moonis,M., 2009

Is Intraarterial tPA Within 3 Hours the Treatment of Choice for Selected Stroke Patients? No
Stroke 40:2613-2614,2615, Lindley,R.I., 2009

Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window: Joint Outcome Table Analysis of the ECASS 3 Trial
Stroke 40:2433-2437,2295, Saver,J.L.,et al, 2009

Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic Stroke: A Metaanalysis
Stroke 40:2438-2441, Lansberg,M.G.,et al, 2009

Stroke Therapy Academic Industry Roundtable (STAIR) Recommendations for Extended Window Acute Stroke Therapy Trials
Stroke 40:2594-2600, Saver,J.L.,et al, 2009

A 70-Year-Old Woman with Shingles: Review of Herpes Zoster
JAMA 302:73-80,108, Whitley,R.J., 2009

A Review of the Evidence for the Use of Telemedicine Within Stroke Systems of Care: A Scientific Statement from the American Heart Association/American Stroke Association
Stroke 40:2616-2634, Schwamm,L.H.,et al, 2009

Recommendations for the Implementation of Telemedicine Within Stroke Systems of Care: A Policy Statement From the American Heart Association
Stroke 40:2635-2660, Schwamm,L.H.,et al, 2009

Parkinsons Disease
Lancet 373:2055-2066, Lees,A.J.,et al, 2009

Diagnosis and New Treatments in Muscular Dystrophies
JNNP 80:706-714, Manzur,A.Y. &Muntoni,F., 2009



Showing articles 2700 to 2750 of 10650 << Previous Next >>